全文获取类型
收费全文 | 86711篇 |
免费 | 5198篇 |
国内免费 | 2134篇 |
专业分类
耳鼻咽喉 | 734篇 |
儿科学 | 2759篇 |
妇产科学 | 2733篇 |
基础医学 | 8430篇 |
口腔科学 | 1526篇 |
临床医学 | 7160篇 |
内科学 | 13056篇 |
皮肤病学 | 1424篇 |
神经病学 | 5163篇 |
特种医学 | 2266篇 |
外国民族医学 | 7篇 |
外科学 | 7669篇 |
综合类 | 12533篇 |
现状与发展 | 4篇 |
一般理论 | 7篇 |
预防医学 | 6336篇 |
眼科学 | 1989篇 |
药学 | 8682篇 |
79篇 | |
中国医学 | 8449篇 |
肿瘤学 | 3037篇 |
出版年
2023年 | 1016篇 |
2022年 | 1569篇 |
2021年 | 2946篇 |
2020年 | 2494篇 |
2019年 | 4608篇 |
2018年 | 3981篇 |
2017年 | 3308篇 |
2016年 | 2277篇 |
2015年 | 2226篇 |
2014年 | 4744篇 |
2013年 | 5543篇 |
2012年 | 4773篇 |
2011年 | 4980篇 |
2010年 | 3940篇 |
2009年 | 3517篇 |
2008年 | 3364篇 |
2007年 | 3369篇 |
2006年 | 2997篇 |
2005年 | 2757篇 |
2004年 | 2209篇 |
2003年 | 2149篇 |
2002年 | 1633篇 |
2001年 | 1560篇 |
2000年 | 1257篇 |
1999年 | 1176篇 |
1998年 | 1012篇 |
1997年 | 981篇 |
1996年 | 876篇 |
1995年 | 908篇 |
1994年 | 746篇 |
1993年 | 601篇 |
1992年 | 566篇 |
1991年 | 496篇 |
1990年 | 510篇 |
1989年 | 446篇 |
1988年 | 328篇 |
1986年 | 343篇 |
1985年 | 1062篇 |
1984年 | 1453篇 |
1983年 | 1041篇 |
1982年 | 1121篇 |
1981年 | 1041篇 |
1980年 | 998篇 |
1979年 | 908篇 |
1978年 | 805篇 |
1977年 | 578篇 |
1976年 | 675篇 |
1975年 | 537篇 |
1974年 | 505篇 |
1973年 | 413篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.
83.
Due to the optimal results obtained in kidney transplantation and to the lack of interest of the industries, new innovative drugs in kidney transplantation are difficult to be encountered. The best strategy to find the new drugs recently developed or under development is to search in the sections of kidney trans plantation still not completely covered by the drugs on the market. These unmet needs are the prevention of delayed graft function (DGF), the protection of the graft over the long time and the desensitization of preformed anti human leukocyte antigen antibodies and the treatment of the acute antibody-mediated rejection. These needs are particularly relevant due to the expansion of some kind of kidney transplantation as transplantation from non-heart beating donor and in the case of antibody-incompatible grafts. The first are particularly exposed to DGF, the latter need a safe desensitization and a safe treatments of the antibody mediated rejections that often occur. Particular caution is needed in treating these drugs. First, they are described in very recent studies and the follow-up of their effect is of course rather short. Second, some of these drugs are still in an early phase of study, even if in well-conducted randomized controlled trials. Particular caution and a careful check need to be used in trials launched 2 or 3 years ago. Indeed, is always necessary to verify whether the study is still going on or whether and why the study itself was abandoned. 相似文献
84.
目的 探讨导致持续性特发性耳鸣严重程度的相关因素。 方法 分析870例持续性特发性主观性耳鸣患者的一般资料、病史、听力学结果、耳鸣匹配实验、耳鸣残疾量表、匹兹堡睡眠质量指数量表和焦虑自评量表,应用多因素Logistic回归分析研究与患者耳鸣严重程度相关的因素。 结果 (1)性别(P<0.001)、年龄(P=0.010)、耳鸣主调声频率(P=0.005)、听力损失(P=0.037)、焦虑程度(P<0.001)、睡眠状况(P<0.001)在THI分级上差异有统计学意义(P<0.05);(2)病程(P=0.053)、侧别(P=0.437)、主调声响度(P=0.120)在THI分级上差异均无统计学意义(P>0.05)。 结论 女性患者特发性耳鸣的程度较男性更为严重;低频较高频更扰人;焦虑程度和睡眠状况是影响耳鸣严重程度的因素,而病程、侧别、耳鸣主调声响度不是影响患者特发性耳鸣严重程度的因素。 相似文献
85.
86.
《L'Encéphale》2022,48(2):179-187
Recent contradictory data has renewed discussion regarding the existence of adult hippocampal neurogenesis (AHN) in humans, i.e., the continued production of new neurons in the brain after birth. The present review revisits the debate of AHN in humans from a historical point of view in the face of contradictory evidence, analyzing the methods employed to investigate this phenomenon. Thus, to date, of the 57 studies performed in humans that we reviewed, 84% (48) concluded in favor of the presence of newborn neurons in the human adult hippocampus. Besides quality of the tissue (such as postmortem intervals below 26 hours as well as tissue conservation and fixation), considerations for assessing and quantify AHN in the human brain require the use of stereology and toxicological analyses of clinical data of the patient. 相似文献
87.
《Radiography》2020,26(4):e195-e200
IntroductionAdverse events in radiology are quite rare, but they do occur. Radiation safety regulations and the law obligate organizations to report certain adverse events, harm and near misses, especially events related to patients' health and safety. The aim of this study was to describe and analyse incidents related to radiation safety issues reported in Finland.MethodsThe data were collected from incident reports documented by radiology personnel concerning notifications of abnormal events in medical imaging made to the Radiation and Nuclear Safety Authority between 2010 and 2017. During these eight years, 312 reports were submitted. Only events reported from radiology departments were included; nuclear medicine, radiotherapy and animal radiology cases were excluded. The final number of reports was 293 (94%).ResultsThe majority of the 293 approved reports were related to computed tomography (CT, 68.3%) and to X-ray examinations (27.6%). Altogether 82.9% of those irradiated were adults, most of whom were exposed to unnecessary radiation through CT (86.5%), 5.5% were children, and 4.4% pregnant women. The most common effective dose of unnecessary radiation was 1 mSv or less (89.7% of all examinations). The highest effective doses were reported in CT (from under 1 mSv–20 mSv and above). The reasons for the adverse events were incorrect identification (32%), incorrect procedure, site or side (30%); and human errors or errors of knowledge (20%).ConclusionAdverse events occurred especially in CT examinations. It is important to collect and analyse incident data, assess the harmful events, learn from them and aim to reduce adverse events.Implications for practiceThis study emphasizes the need for radiological personnel to obtain evidence-based information on adverse events and focus on training to improve patient safety. 相似文献
88.
Background and aimPatient decision aids for oncological treatment options, provide information on the effect on recurrence rates and/or survival benefit, and on side-effects and/or burden of different treatment options. However, often uncertainty exists around the probability estimates for recurrence/survival and side-effects which is too relevant to be ignored. Evidence is lacking on the best way to communicate these uncertainties. The aim of this study is to develop a method to incorporate uncertainties in a patient decision aid for breast cancer patients to support their decision on radiotherapy.MethodsFirstly, qualitative interviews were held with patients and health care professionals. Secondly, in the development phase, thinking aloud sessions were organized with four patients and 12 health care professionals, individual and group-wise.ResultsConsensus was reached on a pictograph illustrating the whole range of uncertainty for local recurrence risks, in combination with textual explanation that a more exact personalized risk would be given by their own physician. The pictograph consisted of 100 female icons in a 10 x 10 array. Icons with a stepwise gradient color indicated the uncertainty margin. The prevalence and severity of possible side-effects were explained using verbal labels.ConclusionsWe developed a novel way of visualizing uncertainties in recurrence rates in a patient decision aid. The effect of this way of communicating risk uncertainty is currently being tested in the BRASA study (NCT03375801). 相似文献
89.
90.